Expanding Global API Manufacturing Capacity In Dalian

Located in the Songmudao Chemical Industry Park, Flamma Honkai, Dalian serves as a cornerstone for small‑molecule API development and manufacturing in China, supporting programs from early research through commercial supply. The site combines broad production scale — from grams to tens of metric tons — with strong in‑house process development, analytical expertise, and raw material sourcing. Substantial, ongoing investment has expanded capabilities with modern cGMP workshops, advanced containment, and cryogenic and high‑pressure technologies designed to support complex chemistries and demanding timelines.

Strategic location, coastal access, and proximity to major Asian hubs make the facility easy to reach and well positioned within global supply networks. Chinese FDA (NMPA) inspection, cGMP certification, and a drug manufacturing license reinforce regulatory readiness, while full ownership and management ensure operational transparency and consistency. With hundreds of cubic meters of existing capacity and significant expansion underway, the site is built to scale alongside growing clinical and commercial needs.

Check out the full brochure to understand how this integrated platform supports reliable, secure API manufacturing at global scale.